But, 70% of patients with maldigestion associated with CP, are abnormally low nutritional indicators (usually it is the serum levels of fat-soluble vitamins), despite the sub 'subjective improvement of clinical symptoms by means of substitution enzyme therapy [10] . There is a concept that enzyme replacement therapy is given to normalize redigestion and absorption of fat and not only them, to obtain a clinical response. Quantitative determination of fecal fat is considered as the gold standard for assessing the digestion of fats in the context of CP [7] . This method, however, is too technically difficult and carries significant discomfort to be widely used in clinical practice to optimize enzyme replacement therapy. Therefore, in clinical practice, or do not use methods against "subjective control intended dosage of enzyme preparation (EP) or taken into consideration usual scatological study. In the last decade in clinical practice implemented method of appointment of EP depending on the EPI defined research fecal elastase-1. As shown by our study, based only on the data, it is difficult to pick up once the optimal dose of EP.
With this in mind, this study had the following aim is to evaluate the effectiveness individually selected oral enzyme replacement therapy using enzymes to form minimikrosfer in patients with pancreatic and maldigestion enterogenous origin and determine the effect of treatment on the nutritional status of patients.
The work was performed at the Department of Internal Medicine number 1. The study included a control group of healthy volunteers (30 persons) and 135 patients with CP,and 30 patients who had celiac disease combined with CP. All patients were chosen enzyme therapy, based on data 13 С-triglyceride breath test and inspect the spare wires at1 year and 2 years after treatment of EP. The survey involved a re-performance ultrasound of the abdomen, repeated execution General clinical tests (complete blood count, blood chemistry, coprogram, urinalysis), enzyme-linked immunosorbent research quantities of fecal elastase-1, 13 The reliability of the difference data with repeated measurements was evaluated using Wilcoxon method. The reliability of these differences when comparing different groups was evaluated using the method of Mann-Whitney. It was found that long-term treatment of pancreatin patients with CP of EPI can restore (in whole or in part, depending on the initial level EPI) own exocrine function pancreas that may, due to a regeneration proper parenchyma pancreas and improvement pits receipt of enzymes in the lumen of the duodenum due to recovery reflex opening of the sphincter of pancreatic duct. The latter factor largely linked to the normalization of diet, its regularity, cessation of alcohol abuse. Thus, among patients first 2 groups (in fact, these patients with mild EPI) observed EPI to restore normal numbers, as according to the TBT and according fecal elastase-1. At the individual level is concerned mainly patients under 65 years.
In the third group, 22 of 41 patients (53,7% ± 7,8%) experienced a significant improvement in all indicators EPI. Overall, the results were significantly different from the initial (before treatment) data. Among patients of the fourth group also observed a tendency to self improvement pancreas function according to a study of fecal elastase-1, the results of TBT significantly observed great improvements.
Correction dose FP, according to the TBT was performed in all patients that needed it. Patients who were found EPI normalization, it was recommended adherence to diet and intake of enzymes "on demand" with the appearance of bloating or unformed stool, a possible consequence of personal dietary errors.
After 2 years, examined a total 99 patients ( Table 2) . Lost of research we had 2 patients because of death (from causes not linked to the CP), 6 patients refused to participate in further investigation of personal circumstances, and 3 patients changed their residence. Results of follow generally showed that after 2 years of treatment EPI indicators remained generally comparable with those that received 1 year of observation, indicating only partial repayment reduction EPI. Significantly difference appeared only in terms of TTX in patients with mild EPI -in this group of indicators of fecal elastase-1 is not materially different from the data after 1 year of treatment. Such data can be explained, firstly, greater sensitivity to mild EPI, second, the permanent abolition of enzyme therapy in some patients adversely affected the utility is subject NSO in terms of diet and drinking no more than 30 g/day.
The evolution of the body mass index (BMI) of patients are shown in Fig. 1  and Fig. 2 .
Thus, to treat the average BMI among 110 patients was 16,7 ± 1,1 kg/m 2, Observation 1 year -20,9 ± 1,3 kg/m 2 , p <0.0001. After 2 years of followstatistically significant increase in BMI was not, it was 21,0 ± 1,3 kg/m 2 , p =0,189, but he remained in the normal range, which is 18.6 -24.9, i.e. clinical task of eliminating malnutritional status was achieved. Given the relatively low specificity CBT on diagnosis function is pancreas, survey of patients with the help of the dynamics in terms of inappropriate monitoring of patients with established pancreas function. Therefore, data analysis CBT in the long term among patients with CP was not carried out.
CBT was done after 1 year of therapy in patients who had United pathology -CP and celiac disease. Treatment of these patients has included compliance with a gluten-free you use enzymes, the dose of which was picked up by the results of TBT. Especially in attention to was paid utility is NSO patients in this group that carried out for monthly consultations with making dietary adjustments and giving me recommendations on the need to observe a gluten-free diet, and exclude alcohol pereyidan, fatty, fried foods, and -required 'compulsory admission designated EP -minimicrosphere pancreatin in the form of a soluble enteric capsule (Creon in individual dose). The results of the comparative evaluation of data fecal elastase-1 and CBT are given in the tTable 3. Analyzing these data, we can note that none of the groups divided by the level of severity of faecal elastase-1 have been no significant changes in their own exocrine function Software patients studied. But in all groups was found significant reduction of amylase insufficiency. Assuming that the level amylaseforming pancreas tool, which, as was previously shown to correlate with data fecal elastase-1, also stayed Uneditable it can make the following assumptions. First, celiac disease is an aggravating factor XII flow and reduce enterogenous EPI stimulation, especially at the initial stage of combined treatment of the two diseases (gluten-free diet, PT) substantially prevents the regeneration of the parenchyma own pancreas. Secondly, reducing amylase insufficiency is linked primarily to the restoration of the function of the mucous membrane of the small intestine due to a gluten-free diet. Third, patients with celiac disease, accompanied EPI require the compulsory replacement enzyme therapy in the form of enzyme preparations minimicrospheres, without which normalization nutritional status of the patient is impossible, both theoretically and practically. Regarding the latter, we have assessed body mass index of patients before treatment and after 1 year of therapy. In general, the group noted a significant improvement of this indicator: the beginning of the treatment he has averaged 16.7 kg/m 2 , standard deviation σ was 1.2, after 1 year of observation, this figure was 20.2 ± 1.2 kg/m 2 , p <0.0 001.
